Belmont, MA, United States of America

Frank Glavin

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Frank Glavin: Enzyme Therapy for Homocystinuria

Introduction

Frank Glavin is an accomplished inventor located in Belmont, MA, recognized for his significant contributions to enzyme therapy and patent innovations. With a total of three patents, he has demonstrated a keen commitment to advancing medical treatments, particularly in the area of homocystinuria.

Latest Patents

Among his notable patents, Frank Glavin has developed formulations for a drug product that features a PEGylated cystathionine beta synthase protein aimed at treating homocystinuria. This innovation provides dosages and dosing regimens intended to reduce homocysteine levels or enhance cysteine and cystathionine levels in affected subjects. His second patent focuses on optimizing enzyme replacement therapy through a method that involves PEGylating a human truncated cystathionine β-synthase protein with a specific mutation. This innovative process includes in-process monitoring to improve the efficiency of the treatment.

Career Highlights

Throughout his career, Frank has collaborated with esteemed research institutions such as the University of Colorado and has contributed his expertise at Travere Therapeutics Switzerland GmbH. His role in these organizations has underscored his commitment to developing effective pharmaceutical therapies.

Collaborations

Frank Glavin has worked alongside prominent colleagues such as Tomas Majtan and Erez Bublil, enhancing collaborative efforts aimed at revolutionizing enzyme therapy. Their combined knowledge and skills have played a crucial role in advancing the field of healthcare innovations.

Conclusion

Frank Glavin continues to be a pivotal figure in the realm of enzyme therapies. His innovations in the treatment of homocystinuria showcase his dedication to improving patient outcomes through cutting-edge research and development in therapeutic applications. His work not only reflects his inventiveness but also his passion for making significant contributions to medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…